FITC标记的多肽N-乙酰氨基半乳糖转移酶13抗体

¥2980
LMAI Bio
中国/美国/欧洲
2021-07-06 14:12

上海联迈生物工程有限公司

我要认领
上海联迈生物工程有限公司
周经理
13052188602 021-67680335
shlmai@163.com
产品属性
供应商上海联迈生物工程有限公司
数量大量
靶点详见说明书
级别1
目录编号LM-13274R-FITC
克隆性多克隆
抗原来源Rabbit
保质期1年
抗体英文名Anti-GALNT13/FITC
抗体名Anti-GALNT13/FITC
标记物FITC标记
宿主Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep,
适应物种Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep,
免疫原详见说明书
亚型IGg
形态粉末、液体、冻干粉
应用范围ICC=1:50-200 IF=1:50-200
浓度1mg/ml
保存条件-20 °C
规格100ul
产品说明
FITC标记的多肽N-乙酰氨基半乳糖转移酶13抗体
英文名称Anti-GALNT13/FITC
中文名称FITC标记的多肽N-乙酰氨基半乳糖转移酶13抗体
别 名GalNAc-T13; GalNAc T13; GalNAc transferase 13; N acetylgalactosaminyltransferase 13; Polypeptide GalNAc transferase 13; pp GaNTase 13; Protein UDP acetylgalactosaminyltransferase 13; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 13; UDP N acetyl alpha D galactosamine:polypeptide; GLT13_HUMAN.
规格价格100ul/2980元 购买 大包装/询价
说 明 书100ul
研究领域细胞生物 信号转导
抗体来源Rabbit
克隆类型Polyclonal
交叉反应Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep,
产品应用ICC=1:50-200 IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量64kDa
细胞定位细胞膜
性 状Lyophilized or Liquid
浓 度1mg/ml
免 疫 原KLH conjugated synthetic peptide derived from human GALNT13/GalNAc-T13
亚 型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
产品介绍background:
The UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes are substrate-specific proteins that catalyze the transfer of GalNAc (N-acetylgalactosamine) to serine and threonine residues onto various proteins, thereby initiating mucin-type O-linked glycosylation in the Golgi apparatus. GalNAc-T13 (Polypeptide N-acetylgalactosaminyltransferase 13), also known as UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13, is a 556 amino acid protein that displays much stronger enzymatic activity than GalNAc-1 towards GalNAc transfer to mucin peptides such as Muc5a and Muc7. The N-terminal domain is involved in substrate binding and manganese coordination, while the C-terminal domain is involved in UDP-Gal binding and catalytic reaction. With specific expression in the central nervous system, GalNAc-T13 may be responsible for the synthesis of Tn antigen in neuronal cells, which is a universal carcinoma marker on malignant cells.

Function:
GALNT13 is a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAcT; EC 2.4.1.41) family, which initiate O-linked glycosylation of mucins by the initial transfer of N-acetylgalactosamine (GalNAc) with an alpha-linkage to a serine or threonine residue. It is specifically expressed in neuronal cells; expressed in fetal brain, whole adult brain, cerebral cortex and cerebellum; not expressed in other tissues tested. There are two named isoforms.

Subcellular Location:
Golgi apparatus membrane; Single pass type II membrane protein.

Tissue Specificity:
Specifically expressed in neuronal cells. Expressed in fetal brain, whole adult brain, cerebral cortex and cerebellum. Not expressed in other tissues tested.

Similarity:
Belongs to the glycosyltransferase 2 family. GalNAc-T subfamily. 
Contains 1 ricin B-type lectin domain. 

Database links:

Entrez Gene: 114805 Human

Entrez Gene: 271786 Mouse

Entrez Gene: 311039 Rat

Entrez Gene: 532545 Cow

Omim: 608369 Human

SwissProt: Q8IUC8 Human

SwissProt: Q8CF93 Mouse

SwissProt: Q6UE39 Rat



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.